Kazuo Izumi

Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial

Kohjiro Ueki, Takayoshi Sasako, Yukiko Okazaki et al. · The Lancet Diabetes & Endocrinology · 2017 · 300 citations

Non-pharmacological Intervention, Diabetes Management, Cardiovascular Disease +9

Clinical Epidemiology of Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) in Japan: Report of the COVID-19 Registry Japan

Nobuaki Matsunaga, Kayoko Hayakawa, Mari Terada et al. · Clinical Infectious Diseases · 2020 · 204 citations · Full text

Levels of IAA, Cytokinins, ABA and Ethylene in Rice Plants as Affected by a Gibberellin Biosynthesis Inhibitor, Uniconazole-P.

Kazuo Izumi, Sachiko Nakagawa, Masatomo Kobayashi et al. · Plant and Cell Physiology · 1988 · 107 citations

Biology, Gibberellin Biosynthesis Inhibitor, Biosynthesis +15

Japan’s initiative on rare and undiagnosed diseases (IRUD): towards an end to the diagnostic odyssey

Takeya Adachi, Kazuo Kawamura, Yoshihiko Furusawa et al. · European Journal of Human Genetics · 2017 · 96 citations · Full text

Japan Agency, Genetic Epidemiology, Diagnosis +31

Effects of Propyzamide on Tobacco Cell Microtubules In Vivo and In Vitro

Tomohiro Akashi, Kazuo Izumi, Eiki Nagano et al. · Plant and Cell Physiology · 1988 · 81 citations

Cytoskeleton, Cellular Physiology, Nicotine +17